Bayesian Capital Management’s Qiagen QGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-29,235
Closed -$1.35M 1053
2023
Q4
$1.35M Buy
29,235
+5,478
+23% +$233K 0.14% 179
2023
Q3
$1.02M Buy
23,757
+8,049
+51% +$375K 0.12% 219
2023
Q2
$750K Buy
+15,708
New +$757K 0.08% 324
2023
Q1
Sell
-14,297
Closed -$756K 1040
2022
Q4
$756K Buy
14,297
+8,111
+131% +$400K 0.11% 249
2022
Q3
$271K Buy
6,186
+1,413
+30% +$69.8K 0.05% 444
2022
Q2
$239K Sell
4,773
-16,769
-78% -$818K 0.04% 562
2022
Q1
$1.12M Buy
+21,542
New +$1.11M 0.17% 182
2020
Q3
Sell
-5,658
Closed -$257K 660
2020
Q2
$257K Sell
5,658
-11,643
-67% -$521K 0.06% 387
2020
Q1
$763K Buy
+17,301
New +$676K 0.16% 183
2019
Q2
Sell
-7,116
Closed -$307K 656
2019
Q1
$307K Sell
7,116
-37,534
-84% -$1.51M 0.06% 383
2018
Q4
$1.63M Buy
44,650
+14,348
+47% +$533K 0.33% 60
2018
Q3
$1.22M Buy
30,302
+19,834
+189% +$792K 0.2% 138
2018
Q2
$401K Buy
+10,468
New +$385K 0.09% 321
2017
Q3
Sell
-8,655
Closed -$308K 612
2017
Q2
$308K Buy
+8,655
New +$292K 0.11% 282

Other funds holding QGEN

Bayesian Capital Management's QGEN Position: Q1 2024 in Review

Bayesian Capital Management sold out of Qiagen (QGEN) in Q1 2024, closing a stake of 29,235 shares — an estimated $1.35M sold.

Bayesian Capital Management first reported a position in QGEN in Q2 2017 and held it in 14 quarters. The position peaked at $1.63M in Q4 2018. 282 funds tracked by Wall St. Rank hold QGEN as of Q1 2024.

  • Bayesian Capital Management reported no remaining Qiagen position as of Q1 2024 after selling out during the quarter.
  • Bayesian Capital Management sold 29,235 Qiagen shares in Q1 2024, an estimated $1.35M.
  • Bayesian Capital Management first reported a position in Qiagen in Q2 2017 and held it in 14 quarters.
  • Bayesian Capital Management's Qiagen position peaked at $1.63M in Q4 2018.
  • 282 funds tracked by Wall St. Rank held Qiagen as of Q1 2024.

Based on Bayesian Capital Management's 13F filing for Q1 2024, filed 15 May 2024.